论文部分内容阅读
Background -We evaluated whether contrast-enhanced multidetector computed tomography(CE-MDCT) might characterize myocardial infarct(MI) with patterns similar to those obtained by contrast-enhanced magnetic resonance(CE-MR)and studied the underlying mechanisms. Methods and Results -In vivo infarct characterization by CE-MDCT was shown to be feasible between 4 and 20 minutes after contrast injection in 7 pigs with MI. Subsequently, in 16 patients with acute MI and 21 patients with chronic MI, contrast patterns by CE-MDCT were related to CE-MR. Eighteen patients had hypoenhanced regions on early CE-MDCT images at the time of coronary imaging, and 34 patients had hyperenhanced regions on images acquired 10 minutes later. On a segmental basis, there was moderately good concordance of early hypoenhanced regions(92%, κ=0.54, P< 0.001) and late hyperenhanced regions(82%, κ=0.61, P< 0.001) between CE-MDCT and CE-MR. Absolute sizes of early hypoenhanced(6±16 versus 7±16 g, P=0.25) and late hyperenhanced(36±34 versus 31±40 g, P=0.14) regions were similar on CE-MDCT and CE-MR and were highly correlated(r=0.93, P< 0.001 and r=0.89, P< 0.001 respectively). In 8 retrogradely perfused infarcted rabbit hearts, contrast kinetics of iomeprol were similar to gadodiamide, ie, slow wash in(8.7±6.7 versus 1.2±0.3 minutes, P< 0.001) in infarct core and slow washout(20±12 versus 2.5±0.5 minutes, P< 0.001) in both infarct core and rim compared with the remote region. Conclusions -Because iodated contrast agents have similar kinetics in infarcted and noninfarcted myocardium as gadolinium DPTA, CE-MDCT can characterize acute and chronic MI with contrast patterns similar to CE-MR. CE-MDCT may thus provide important information on infarct size and viability at the time of noninvasive coronary imaging.
Background-Weights deemed contrast-enhanced multidetector computed tomography (CE-MDCT) might characterize myocardial infarct (MI) with patterns similar to those obtained by contrast-enhanced magnetic resonance (CE-MR) and studied the underlying mechanisms. Methods and Results - In vivo infarct characterization by CE-MDCT was shown to be feasible between 4 and 20 minutes after contrast injection in 7 pigs with MI. In 16 patients with acute MI and 21 patients with chronic MI, contrast patterns by CE-MDCT were related to CE-MR. Eighteen patients had hypoenhanced regions on early CE-MDCT images at the time of coronary imaging, and 34 patients had hyperenhanced regions on images acquired 10 minutes later. On a segmental basis, there was moderately good concordance of early hypoenhanced regions Absolute sizes of early hypoenhanced (6 ± 16 versus 7 ± 16) were significantly higher in CE-MDCT compared with CE-MRCT (92%, κ = 0.54, P <0.001) g, P = 0.25) and late h P <0.001 and r = 0.89, P <0.001 respectively). In (36 ± 34 versus 31 ± 40 g, P = 0.14) regions were similar on CE-MDCT and CE- 8 retrogradely perfused infarcted rabbit hearts, contrast kinetics of iomeprol were similar to gadodiamide, ie, slow wash in (8.7 ± 6.7 versus 1.2 ± 0.3 minutes, P <0.001) in infarct core and slow washout (20 ± 12 versus 2.5 ± 0.5 minutes , P <0.001) in both infarct core and rim compared with the remote region. Conclusions -Because iodated contrast agents have similar kinetics in infarcted and noninfarcted myocardium as gadolinium DPTA, CE-MDCT can characterize acute and chronic MI with contrast patterns similar to CE -MR. CE-MDCT may there provide important information on infarct size and viability at the time of noninvasive coronary imaging.